{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:57:54Z","timestamp":1770037074088,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jvoice.2014.08.011","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T10:43:16Z","timestamp":1411123396000},"page":"352-355","source":"Crossref","is-referenced-by-count":19,"title":["Factors Influencing Botulinum Toxin Dose Instability in Spasmodic Dysphonia Patients"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-0158","authenticated-orcid":false,"given":"David E.","family":"Rosow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Pechman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Saint-Victor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaming","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna S.","family":"Lundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy R.","family":"Casiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2014.08.011_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1523\/JNEUROSCI.2758-10.2011","article-title":"Spasmodic dysphonia: a laryngeal control disorder specific to speech","volume":"31","author":"Ludlow","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.jvoice.2014.08.011_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/lary.21395","article-title":"Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes","volume":"121","author":"Novakovic","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2014.08.011_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/000348940711601204","article-title":"Long-term botulinum toxin dose consistency for treatment of adductor spasmodic dysphonia","volume":"116","author":"Holden","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jvoice.2014.08.011_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00005537-199810000-00003","article-title":"Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients","volume":"108","author":"Blitzer","year":"1998","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2014.08.011_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/0194599813484685","article-title":"Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia","volume":"148","author":"Rosow","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2014.08.011_bib6","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0892-1997(98)80055-6","article-title":"The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia","volume":"12","author":"Lundy","year":"1998","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2014.08.011_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CIA.S1416","article-title":"Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection","volume":"3","author":"Cannito","year":"2008","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jvoice.2014.08.011_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/lary.22471","article-title":"Case-control study of risk factors for spasmodic dysphonia: a comparison with other voice disorders","volume":"122","author":"Tanner","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2014.08.011_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000316142","article-title":"The effect of smoking on the dysphonia severity index in females","volume":"63","author":"Awan","year":"2011","journal-title":"Folia Phoniatr Logop"},{"key":"10.1016\/j.jvoice.2014.08.011_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/00016480410017170","article-title":"Neuroimmunological activation of the afferent laryngeal neural circuit in experimentally induced laryngeal inflammation","volume":"125","author":"Park","year":"2005","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jvoice.2014.08.011_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.otohns.2008.10.033","article-title":"Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia","volume":"140","author":"Birkent","year":"2009","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2014.08.011_bib12","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/lary.20564","article-title":"Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia","volume":"119","author":"Vasconcelos","year":"2009","journal-title":"Laryngoscope"},{"issue":"suppl 4","key":"10.1016\/j.jvoice.2014.08.011_bib13","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1002\/lary.22050","article-title":"Adductor spasmodic dysphonia\u2014changes in dosing after prolonged injections","volume":"121","author":"Chinosornvatana","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2014.08.011_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jvoice.2008.08.003","article-title":"Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception","volume":"24","author":"Braden","year":"2010","journal-title":"J Voice"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199714001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199714001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T12:24:03Z","timestamp":1538223843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199714001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0892199714001787"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2014.08.011","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}